BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19457324)

  • 1. [Agranulocytosis from metamizole: a potential problem for the British population].
    Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
    Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia, agranulocytosis and dipyrone.
    Hamerschlak N; Cavalcanti AB
    Sao Paulo Med J; 2005 Sep; 123(5):247-9. PubMed ID: 16358101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J
    South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?
    Shah RR
    J Clin Pharm Ther; 2019 Feb; 44(1):129-133. PubMed ID: 30311250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgery, dipyrone, and agranulocytosis in Latin America].
    Sánchez Medal L
    Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731
    [No Abstract]   [Full Text] [Related]  

  • 13. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
    Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL; Ibáñez Camacho MF; López Pérez E
    Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract]   [Full Text] [Related]  

  • 17. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dual agranulocytosis episode likely resulting from metamizole use].
    Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
    Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leukopenia with unclear fever].
    Mayer S; Kündiger T; Schrader H
    Internist (Berl); 2017 Jul; 58(7):740-744. PubMed ID: 28265684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.